Tarsus Pharmaceuticals
Patents, Design & Utilities

Last updated:

List of all Tarsus Pharmaceuticals patents 9 in total

Status Patent
Application
Utility: ISOXAZOLINE PARASITICIDE FORMULATIONS AND METHODS FOR TREATING BLEPHARITIS External link
Filling date: 26 Sep 2025 Issue date: 11 Aug 2022
Application
Utility: SYSTEMIC ISOXAZOLINE PARASITICIDES FOR VECTOR-BORNE AND VIRAL DISEASE TREATMENT OR PROPHYLAXIS External link
Filling date: 26 Sep 2025 Issue date: 26 May 2022
Application
Utility: PHARMACEUTICAL COMPOSITIONS FOR DEMODEX RELATED BLEPHARITIS AND EYELID CRUSTING External link
Filling date: 26 Sep 2025 Issue date: 28 Apr 2022
Application
Utility: METHODS FOR TREATING OCULAR DEMODEX USING SPINOSAD FORMULATIONS External link
Filling date: 26 Sep 2025 Issue date: 24 Feb 2022
Grant
Utility: Isoxazoline parasiticide formulations and methods for treating blepharitis External link
Filling date: 26 Sep 2025 Issue date: 14 Dec 2021
Application
Utility: ISOXAZOLINE PARASITICIDE FORMULATIONS AND METHODS FOR TREATING BLEPHARITIS External link
Filling date: 26 Sep 2025 Issue date: 1 Jul 2021
Application
Utility: ISOXAZOLINE PARASITICIDE FORMULATIONS AND METHODS FOR TREATING BLEPHARITIS External link
Filling date: 26 Sep 2025 Issue date: 18 Mar 2021
Application
Utility: ISOXAZOLINE PARASITICIDE FORMULATIONS AND METHODS FOR TREATING BLEPHARITIS External link
Filling date: 26 Sep 2025 Issue date: 18 Mar 2021
Grant
Utility: Methods for treating ocular demodex using isoxazoline parasiticide formulations External link
Filling date: 26 Sep 2025 Issue date: 17 Nov 2020

Showing 1 to 9 of 9 patents.